← Open Payments lookup

PETER DEBELIUS-ENEMARK: Open Payments

NPI 1376593913 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,062 in 54 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $610 · 2025 $1,062

Food & beverage: $1,062
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.10$165
Alkermes, Inc.7$151
E.R. Squibb & Sons, L.L.C.11$143
Vanda Pharmaceuticals Inc.4$106
Lundbeck LLC4$97
Neurocrine BioSciences, Inc.3$80
Axsome Therapeutics, Inc.3$72
Teva Pharmaceuticals USA, Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
ABBVIE INC.2$43

Products named: REXULTI, COBENFY, LYBALVI, FANAPT, INGREZZA, AUSTEDO XR, CAPLYTA, VRAYLAR.

Industry payments across FL — which companies pay providers there.